96955 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Tumour necrosis factor [TNF]
Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing
#302Trail cell-penetrating peptide-like mutant MUR6 and preparation method thereof
#303Solubility and Affinity Tag for Recombinant Protein Expression and Purification
#304Mesenchymal Stem Cells Expressing Biomarkers that Predict the Effectiveness of Mesenchymal Stem Cells for Treating Diseases and Disorders
#305Methods for treating cancer with EGFR nanobodies linked to DR5 binding moieties
#306IMMOBILIZED TUMOR NECROSIS FACTOR-ALPHA MUTEINS FOR ENHANCING IMMUNE RESPONSE IN MAMMALS
#307Deglycosylation reagents and methods
#308Enhanced adoptive cell therapy
#309Methods for cancer therapy using mutant light molecules with increased affinity to receptors
#310Pharmaceutical compositions and their use for the treatment of autoimmune disorders
#311GITRL-collectin fusion proteins and encoding nucleic acids
#312SINGLE-CHAIN FUSION POLYPEPTIDE COMPRISING TRAIL
#313GITRL fusion proteins comprising a human coronin 1a derived trimerization domain
#314Polypeptides and uses thereof for reducing CD95-mediated cell motility
#315MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#316Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#317Substrates and methods for collection, stabilization and elution of biomolecules
#318Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#319Modified polynucleotides for the production of secreted proteins
#320Artificial signal peptide
#321April variants
#322Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules
#323METHODS FOR ENHANCING THE DELIVERY OF ACTIVE AGENTS
#324Treatment of gum diseases and gum disorders with TSG-6 protein
#325Methods for treating cancer
#326Methods of administering an N-terminal modified PEG-TRAIL
#327Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease
#328CD27 single chain molecules and encoding nucleic acids
#329Tumor necrosis factor receptor soluble factor binding (TNFRSF-binding) agents
#330Antibodies against phosphorylcholine in combination therapy with biologic agents
#331Phosphorylcholine in combination therapy with infliximab
#332Polynucleotide molecules and uses thereof
#333Composition comprising a mixture of CD95-Fc isoforms
#334Compositions and methods for treatment of cancer
#335EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF
#336Composition for Enhancing Transgene Expression in Eukaryotic Cells and Method for Enhancing Production of a Target Protein Encoded by a Transgene
#337Compositions and methods for treatment of cancer
#338CD40L collectin fusion proteins and encoding nucleic acid molecules
#339Compositions and methods for treatment of cancer
#340Targeted modified TNF family members
#341Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#342Modified polynucleotides for the production of proteins
#343Compositions and methods for treatment of cancer
#344ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS OF REGULATING IRON METABOLISM
#345Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein
#346Production of TSG-6 Protein
#347Modified polynucleotides for the production of biologics and proteins associated with human disease
#348Immunoconjugates for the treatment of tumours
#349MOLECULAR LABELING METHODS
#350Diagnosis and Treatment of Arthritic Conditions
#351Method of predicting survival time in myocardial infarction patients by measuring BAFF levels
#352Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
#353In vivo production of proteins
#354Modified polynucleotides for the production of secreted proteins
#355PD-L1 and PD-L2-based fusion proteins and uses thereof
#356Fusion proteins that facilitate cancer cell destruction
#357NANOBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA
#358Deglycosylation Reagents and Methods
#359Albumin fusion proteins
#360Methods of treating neurological diseases
#361Enhanced adoptive cell therapy
#362METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2, AND IL2 IN PATIENTS
#363Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease
#364Composition comprising a mixture of CD95-Fc isoforms and methods of producing same
#365Multifunctional nanobodies for treating cancer
#366METHOD FOR PRODUCING MONOMERIC AND MULTIMERIC MOLECULES AND USES THEREOF
#367Method of manufacturing a protein by perfusion in media with a low amino acid concentration
#368Albumin fusion proteins
#369α/β-peptide mimics of Z-domain peptides
#370Oncolytic virus therapy for resistant tumors
#371Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#372HUMAN FUSION PROTEINS COMPRISING SINGLE CHAIN TNFALPHA AND TARGETING DOMAINS
#373Low acidic species compositions and methods for producing and using the same using displacement chromatography
#374Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
#375Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#376Modified polynucleotides for the production of cosmetic proteins and peptides
#377Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)
#378Serpin fusion polypeptides and methods of use thereof
#379FUSION PROTEINS FORMING TRIMERS
#380Trail collectin fusion proteins
#381Single chain trail fusion polypeptides and encoding nucleic acids
#382Low acidic species compositions and methods for producing and using the same using displacement chromatography
#383Single chain CD40L fusion polypeptides
#384Serpin fusion polypeptides and methods of use thereof
#385Alteration of cell membrane for new functions using IL-2 and streptavidin
#386Compositions for cancer therapy using mutant light molecules with increased affinity to receptors
#387The IgM and IgE Heavy Chain Domain 2 as Covalently Linked Homodimerization Modules for the Generation of Fusion Proteins with Dual Specificity
#388Chimeric molecule involving oligomerized FasL extracellular domain
#389ANTICANCER FUSION PROTEIN
#390ANTICANCER FUSION PROTEIN
#391Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof
#392Chemically and thermodynamically stable insulin analogues and improved methods for their production
#393Arginine-free TNFR:Fc-fusion polypeptide compositions and methods of use
#394EDAR ligand derived peptides and use thereof
#395RANK LIGAND POLYPEPTIDES
#396Regulation of energy metabolism and obesity by modulating a proliferation-inducing ligand (APRIL) or APRIL signaling
#397Immunocytokine combination therapy
#398VARIANTS OF THE TNF SUPERFAMILY AND USES THEREOF
#399Fusion proteins forming trimers
#400Method for attenuating immune response using mesenchymal stem cells and cytokines
#401Engineered TAA antibody-TNFSF member ligand fusion molecules
#402TNF Family Ligand Variants
#403Single chain fusion polypeptides comprising soluble light cytokine domains
#404Methods and compositions for modulating TNF/TNFR signaling
#405Methods for regulating protein function in cells in vivo using synthetic small molecules
#406Serpin fusion polypeptides and methods of purification thereof
#407Gelsolin stimulation of blood samples using gold particles
#408Peptide library
#409Conjugates for the treatment of mesothelioma
#410Affinity peptides toward infliximab
#411Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide and nucleic acids encoding the same
#412Use of chimeric antigen receptor-modified T-cells to treat cancer
#413STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF
#414Hyaluronic acid-protein conjugates and method for preparing same
#415VEGF-activated trail ligands
#416Virus like particle composition
#417Anticancer fusion protein comprising TRAIL and interferon
#418Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same
#419Methods for treating TWEAK-related conditions
#420BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#421TNF superfamily collectin fusion proteins and encoding nucleic acids
#422Heterodimeric human IgG1 polypeptides with isoelectric point modifications
#423Anticancer fusion protein comprising trail
#424Method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
#425Treatment of vascular complications of diabetes
#426APO-2 LIGAND VARIANTS AND USES THEREOF
#427LIGHT TARGETING MOLECULES AND USES THEREOF
#428Method for treatment of post operative cognitive dysfunction
#429Organic compound for the regulation of vectorial ion channels
#430Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof
#431Compositions and methods for the treatment of immune related diseases
#432TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases
#433MULTIMERIC FORMS OF THERAPEUTIC PROTEINS AND USES THEREOF
#434Serpin fusion polypeptides and methods of use thereof
#435Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin
#436Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents
#437METHODS OF IDENTIFYING OBM MODULATORS
#438GLUCOCEREBROSIDASE MULTIMERS AND USES THEREOF
#439METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2 AND IL2 IN PATIENTS
#440Peptides for active anti-cytokine immunization
#441MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN
#442Modified food grade microorganism for treatment of inflammatory bowel disease
#443Regulation of energy metabolism and obesity by modulating B cell activating factor (BAFF, BLYS) or BAFF signaling
#444Alteration of cell membrane for new functions
#445Receptor activator of NF-kappaB
#446Nucleic acids encoding TNFγ
#447TNF superfamily member light fusion proteins
#448STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF
#449Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof
#450Method for in vivo expansion of T regulatory cells
#451Colloidal metal compositions and methods
#452THERAPEUTIC REGIMEN FOR TREATING CANCER
#453Peptides for active anti-cytokine immunization
#454Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
#455Methods for making Apo-2 Ligand using divalent metal ions
#456DIRECTED RADIOTHERAPY
#457Albumin fusion proteins
#458Fusion proteins forming trimers
#459COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#460Cells and methods for producing blocking antibodies to human RANKL
#461Humanized GM-CSF antibodies
#462METHODS FOR TREATING TWEAK-RELATED CONDITIONS
#463BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#464Human tumor necrosis factor-α mutants
#465Chimeric activators: quantitatively designed protein therapeutics and uses thereof
#466CONJUGATES FOR THE TREATMENT OF MESOTHELIOMA
#467Kits for detecting rank
#468CYTOKINE DESIGN
#469Peptides for active anti-cytokine immunization
#470Nucleic acid encoding TNFx protein
#471Single-chain TNFSF fusion polypeptides
#472METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2, AND IL2 IN PATIENTS
#473Cyclic, cystein-free protein
#474Combinatorial Libraries Based on C-type Lectin-like Domain
#475Method of inhibiting osteoclast activity
#476Methods of immune modulation with death receptor-induced apoptosis
#477THERAPEUTIC REGIMEN FOR TREATING CANCER
#478CRYSTAL STRUCTURE OF OX40L AND OX40L COMPLEXED WITH OX40 RECEPTOR
#479CD95L or trail fusion proteins
#480Reverse protein
#481Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
#482Increased T-cell tumor infiltration and eradication of metastases by mutant light
#483Albumin fusion proteins
#484Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains
#485Novel Peptides and Their Use for the Treatment of Edema
#486Compositions and methods for treatment of angiogenesis in pathological lesions
#487Immunoconjugates for the treatment of tumours
#488Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#489Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
#490NANOPARTICLE-MEDIATED TREATMENT FOR INFLAMMATORY DISEASES
#491Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains
#492Methods of diagnosing and prognosing hodgkin's lymphoma
#493Tumor necrosis factor-alpha mutants
#494Collectin fusion proteins comprising TNF or trail
#495MODIFIED CYTOKINES FOR USE IN CANCER THERAPY
#496Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs
#497CRYPTIC GLYCAN MARKERS AND APPLICATIONS THEREOF
#498Humanized GM-CSF antibodies
#499Compositions and methods for the treatment of immune related diseases
#500TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS
#501Peptides for active anti-cytokine immunization
#502Colloidal metal compositions and methods
#503ANTIBODIES THAT BIND TO OBM
#504Light targeting molecules and uses thereof
#505Mammalian genes; related reagents and methods
#506TNF-alpha VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-alpha
#507GITR LIGAND AND GITR LIGAND-RELATED MOLECULES AND ANTIBODIES AND USES THEREOF
#508Tumour Suppressor Protein
#509Method for regulating protein function in cells in vivo using synthetic small molecules
#510Methods for treating TWEAK-related conditions
#511Enhancing the circulating half-life of antibody-based fusion proteins
#512Nucleic Acids Encoding Multimeric Fusion Proteins of TNF Superfamily Ligands
#513Human GM-CSF antibodies
#514MOLECULES AND CHIMERIC MOLECULES THEREOF
#515Immobilized tumor necrosis factor-α muteins for enhancing immune response in mammals
#516NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
#517LITAF binding site peptides and methods of using the same
#518VEGF-activated ligands
#519N-terminal modified PEG-TRAIL
#520Kit containing stem cells and cytokines for use in attenuating immune responses
#521TNF antagonists
#522Mammalian genes; related reagents and methods
#523Apo-2 ligand variants and uses thereof
#524CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases
#525ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
#526Albumin Fusion Proteins
#527Albumin Fusion Proteins
#528Increased T-cell tumor infiltration and eradication of metastases by mutant light
#529Alteration of cell membrane with FasL
#530BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#531Serum albumin binding proteins
#532Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof
#533Methods for interfering with rank signaling
#534Methods of Increasing Cancer Sensitivity to Chemotherapeutic Agents Using Chimeric ISF35
#535Deregulated Genes and/or Processes in Inflammatory Arthritis
#536Process For the Isolation and/or Purification of Proteins
#537Ligands and libraries of ligands
#538Peptides for active anti-cytokine immunization
#539Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
#540C1q Related Protein
#541Albumin fusion proteins
#542Antibodies to OCIF-binding molecules
#543Pharmaceutical compositions for the treatment of TNF-α related disorders
#544Virus-like particles for the induction of autoantibodies
#545Albumin Fusion Proteins
#546Albumin fusion proteins comprising insulin polypeptides
#547Albumin Fusion Proteins
#548G-CSF-albumin fusion proteins
#549Albumin fusion proteins
#550METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2, AND IL2 IN PATIENTS
#551Pharmaceutically acceptable Fn3 Polypeptides for human treatments
#552Method for Rational Pegylation of Proteins
#553Selection of fibronectin scaffolds using nucleic acid-protein fusions
#554ISOLATION OF ANTIBODIES THAT CROSS-REACT AND NEUTRALIZE RANKL ORIGINATING FROM MULTIPLE SPECIES
#555Method for producing recombinant proteins
#556Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine
#557Method for enhancing immune responses in mammals
#558Fibronectin derivative Fc fusions
#559Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
#560Recombinant A2-specific TNFα-specific antibodies
#561Carrier Conjugates Of Tnf-Peptides
#562High affinity fibronectin derivatives
#563Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
#564Kits for detecting rank nucleic acids
#565Methods of treating rheumatoid arthritis with anti-TNF antibodies
#566Recombinant polypeptides of the members of the TNF ligand family and use thereof
#567Albumin fusion proteins
#56832 Human Secreted Proteins
#569Albumin fusion proteins
#570MODULATOR OF TNF/NGF SUPERFAMILY RECEPTORS AND SOLUBLE OLIGOMERIC TNF/NGF SUPERFAMILY RECEPTORS
#571Colloidal metal compositions and methods
#572TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
#573Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6
#574Methods for making Apo-2 ligand using divalent metal ions
#575Human Tumor Necrosis Factor TR20 and Methods Based Thereon
#576Colloidal metal compositions and methods
#577TNF-like secreted protein
#578Methods of treating psoriasis with anti-TNF antibodies
#579Compositions and methods for cancer immunotherapy
#580Tumour suppressor protein
#581Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereof
#582Methods of inhibiting TNFα activity in the blood of a patient
#583Protein scaffolds for antibody mimics and other binding proteins
#584DNA19355 polypeptide, a tumor necrosis factor homolog
#585Isolated INSP 163 protein
#586Apo2l(trail) receptor binding peptides and uses thereof
#587Method for enhancing immune responses in mammals
#588Pharmaceutical composition for preventing or treating malignant glioma
#589Modified peptides as therapeutic agents
#590Compositions and methods for the treatment of immune related diseases
#591Modified cytokines for use in cancer therapy
#592Crystalline Neutrokine-alpha protein, method of preparation thereof, and method of use thereof
#593Trimeric binding proteins for trimeric cytokines
#594Methods of treating inflammation associated with viral infection with anti-TNF antibodies
#595Antibodies to OCIF-binding molecules
#596PEGylated TNF-α variant proteins
#597Potentialization of the activation of high molecular weight prodrugs
#598Methods of inhibiting TNF-α in patients with Crohn's disease
#599Albumin fusion proteins
#600Pharmaceutical preparations of Fn3 polypeptides for human treatments